Clinical trial
Intramyocardial Transplantation of Bone Marrow Stem Cells for Improvement of Post-infarct Myocardial Regeneration in Addition to CABG Surgery: a Controlled, Prospective, Randomized, Double Blinded Multicenter Trial (PERFECT)
NCT00950274 is registered in ClinicalTrials.gov with Miltenyi Biotec B.V. & Co. KG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intramyocardial Transplantation of Bone Marrow Stem Cells for Improvement of Post-infarct Myocardial Regeneration in Addition to CABG Surgery: a Controlled, Prospective, Randomized, Double Blinded Multicenter Trial (PERFECT)
- Lead sponsor
- Miltenyi Biotec B.V. & Co. KG
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- July 31, 2009
- Completion date
- September 30, 2017
- Enrollment
- 81 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.